C. Elegans as model for drug discovery

Current Topics in Medicinal Chemistry

Volumn 17, Issue 18, 2017, Pages 2067-2076

  Carretero, Maria ^a   Solis, Gregory M ^a   Petrascheck, Michael ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

C. elegans; Cancer biology; Drug discovery; HTS; Nematodes; Vertebrate vascular endothelial growth factors

Indexed keywords

AMYLOID BETA PROTEIN; BENOMYL; CLOZAPINE; CYPROHEPTADINE; G PROTEIN COUPLED RECEPTOR; GELDANAMYCIN; LEVAMISOLE; LITHIUM; METFORMIN; NORADRENALIN; OCTOPAMINE; RAPAMYCIN; ROTENONE; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; MOLECULAR LIBRARY;

APOPTOSIS; ARTICLE; BACTERIAL VIRULENCE; CAENORHABDITIS ELEGANS; DEGENERATIVE DISEASE; DNA DAMAGE; DNA TRANSCRIPTION; DRUG DEVELOPMENT; DRUG METABOLISM; DRUG SCREENING; DRUG UPTAKE; ENTEROCOCCUS FAECALIS; HERMAPHRODITE; HIGH THROUGHPUT SCREENING; IMMUNE RESPONSE; INNATE IMMUNITY; MASS SPECTROMETRY; MITOCHONDRIAL BIOGENESIS; NERVE CELL DIFFERENTIATION; NONHUMAN; PARASITOSIS; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN HOMEOSTASIS; VALIDATION STUDY; ANIMAL; ANIMAL MODEL; DRUG EFFECTS; MOLECULAR LIBRARY; PHARMACOLOGY; PROCEDURES;

ANIMALS; CAENORHABDITIS ELEGANS; DRUG DISCOVERY; MODELS, ANIMAL; SMALL MOLECULE LIBRARIES;

EID: 85021051575     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026617666170131114401     Document Type: Article

References (123)

1. Kaletta, T.; Hengartner, M.O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov., 2006, 5(5), 387-398.
2. Lord, C.E.; Gunawardena, A.H. Programmed cell death in C. elegans, mammals and plants. Eur. J. Cell. Biol., 2012, 91(8), 603-613.
3. Moreno-Arriola, E.; Cardenas-Rodriguez, N.; Coballase-Urrutia, E.; Pedraza-Chaverri, J.; Carmona-Aparicio, L.; Ortega-Cuellar, D. Caenorhabditis elegans: A useful model for studying metabolic disorders in which oxidative stress is a contributing factor. Oxid. Med. Cell. Longev., 2014, 2014, 705253.
4. Irazoqui, J.E.; Urbach, J.M.; Ausubel, F.M. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol., 2010, 10(1), 47-58.
5. McKay, R.M.; McKay, J.P.; Avery, L.; Graff, J.M. C elegans: a model for exploring the genetics of fat storage. Dev. Cell., 2003, 4(1), 131-42.
6. Liu, D. Where do new medicines come from? CBE. Life. Sci. Educ., 2011, 10(2), 135-141.
7. Swinney, D.C.; Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov., 2011, 10(7), 507-519.
8. Schwarz, E.M. Genomic classification of protein-coding gene families. WormBook., 2005, 1-23
9. Consortium, C.e. S. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science, 1998, 282(5396) , 2012-2018.
10. Sonnhammer, E.L.; Durbin, R. Analysis of protein domain families in Caenorhabditis elegans. Genomics, 1997, 46(2) , 200-216;
11. Thomas, J.H. Genome evolution in Caenorhabditis. Brief. Funct. Genomic. Proteomic., 2008, 7(3), 211-6.
12. Lai, C.H.; Chou, C.Y.; Ch'ang, L.Y.; Liu, C.S.; Lin, W. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res., 2000, 10(5), 703-713.
13. Kuwabara, P.E.; O'Neil, N. The use of functional genomics in C. elegans for studying human development and disease. J. Inherit. Metab. Dis., 2001, 24(2), 127-138.
14. Shaye, D.D.; Greenwald, I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One, 2011, 6(5), e20085.
15. Harris, T.W.; Chen, N.; Cunningham, F.; Tello-Ruiz, M.; Antoshechkin, I.; Bastiani, C.; Bieri, T.; Blasiar, D.; Bradnam, K.; Chan, J.; Chen, C.K.; Chen, W.J.; Davis, P.; Kenny, E.; Kishore, R.; Lawson, D.; Lee, R.; Muller, H.M.; Nakamura, C.; Ozersky, P.; Petcherski, A.; Rogers, A.; Sabo, A.; Schwarz, E.M.; Van Auken, K.; Wang, Q.; Durbin, R.; Spieth, J.; Sternberg, P.W.; Stein, L.D. WormBase: a multi-species resource for nematode biology and genomics. Nucleic Acids Res., 2004, 32(Database issue), D411-417.
16. Chen, N.; Lawson, D.; Bradnam, K.; Harris, T.W.; Stein, L.D. WormBase as an integrated platform for the C. elegans ORFeome. Genome. Res., 2004, 14(10B), 2155-2161.
17. Markaki, M.; Tavernarakis, N. Modeling human diseases in Caenorhabditis elegans. Biotechnol. J., 2010, 5(12), 1261-1276.
18. Darby, C. Interactions with microbial pathogens. WormBook, 2005, 1-15.
19. Balla, K.M.; Troemel, E.R. Caenorhabditis elegans as a model for intracellular pathogen infection. Cell. Microbiol., 2013, 15(8), 1313-1322.
20. Diogo, J.; Bratanich, A. The nematode Caenorhabditis elegans as a model to study viruses. Arch. Virol., 2014, 159(11), 2843-51.
21. Bargmann, C.I. Chemosensation in C. elegans. WormBook, 2006, 1-29.
22. Barr, M.M.; Garcia, L.R. Male mating behavior. WormBook, 2006, 1-11.
23. Ardiel, E.L.; Rankin, C.H. An elegant mind: learning and memory in Caenorhabditis elegans. Learn. Mem., 2010, 17(4) , 191-201.
24. Kauffman, A.L.; Ashraf, J.M.; Corces-Zimmerman, M.R.; Landis, J.N.; Murphy, C.T. Insulin signaling and dietary restriction differentially influence the decline of learning and memory with age. PLoS Biol., 2010, 8(5), e1000372.
25. Leinwand, S.G.; Chalasani, S.H. Neuropeptide signaling remodels chemosensory circuit composition in Caenorhabditis elegans. Nat. Neurosci., 2013, 16(10), 1461-1467.
26. Sulston, J.E.; Schierenberg, E.; White, J.G.; Thomson, J.N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol., 1983, 100(1), 64-119.
27. Ellis, R.E.; Horvitz, H.R. Two C. elegans genes control the programmed deaths of specific cells in the pharynx. Development, 1991, 112(2), 591-603.
28. Ellis, R.E.; Jacobson, D.M.; Horvitz, H.R. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics, 1991, 129(1), 79-94.
29. Horvitz, H.R.; Shaham, S.; Hengartner, M.O. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb. Symp. Quant. Biol., 1994, 59, 377-385.
30. Denning, D.P.; Hatch, V.; Horvitz, H.R. Both the caspase CSP-1 and a caspase-independent pathway promote programmed cell death in parallel to the canonical pathway for apoptosis in Caenorhabditis elegans. PLoS Genet., 2013, 9(3), e1003341.
31. Kobet, R.A.; Pan, X.; Zhang, B.; Pak, S.C.; Asch, A.S.; Lee, M.H. Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification. Biomol. Ther(Seoul), 2014, 22(5), 371-383.
32. van Dijk, F.S.; Cobben, J.M.; Kariminejad, A.; Maugeri, A.; Nikkels, P.G.; van Rijn, R.R.; Pals, G. Osteogenesis Imperfecta: A Review with Clinical Examples. Mol. Syndromol., 2011, 2(1), 1-20.
33. Johnstone, I.L.; Shafi, Y.; Barry, J.D. Molecular analysis of mutations in the Caenorhabditis elegans collagen gene dpy-7. EMBO J., 1992, 11(11), 3857-3863.
34. McGary, K.L.; Park, T.J.; Woods, J.O.; Cha, H.J.; Wallingford, J.B.; Marcotte, E.M. Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proc. Natl. Acad. Sci. USA, 2010, 107(14), 6544-6549.
35. Dryja, T.P.; Cavenee, W.; White, R.; Rapaport, J.M.; Petersen, R.; Albert, D.M.; Bruns, G.A. Homozygosity of chromosome 13 in retinoblastoma. N. Engl. J. Med., 1984, 310(9), 550-553.
36. Lu, X.; Horvitz, H.R. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. Cell, 1998,. 95(7),. 981-991.
37. Tarsitano, M.; De Falco, S.; Colonna, V.; McGhee, J.D.; Persico, M.G. The C. elegans pvf-1 gene encodes a PDGF/VEGF-like factor able to bind mammalian VEGF receptors and to induce angiogenesis. FASEB J., 2006, 20(2), 227-233.
38. Rangaraju, S.; Levey, D.F.; Nho, K.; Jain, N.; Andrews, K.D.; Le-Niculescu, H.; Salomon, D.R.; Saykin, A.J.; Petrascheck, M.; Niculescu, A.B. Mood, stress and longevity: convergence on ANK3. Mol. Psychiatry, 2016, 1037-1049.
39. Petrascheck, M.; Ye, X.; Buck, L.B. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature, 2007, 450(7169), 553-556.
40. Rangaraju, S.; Solis, G.M.; Andersson, S.I.; Gomez-Amaro, R.L.; Kardakaris, R.; Broaddus, C.D.; Niculescu, A.B. 3rd; Petrascheck, M. Atypical antidepressants extend lifespan of Caenorhabditis elegans by activation of a non-cell-autonomous stress response. Aging Cell, 2015, 14(6), 971-981.
41. Kwok, T.C.; Ricker, N.; Fraser, R.; Chan, A.W.; Burns, A.; Stanley, E.F.; McCourt, P.; Cutler, S.R.; Roy, P.J. A smallmolecule screen in C. elegans yields a new calcium channel antagonist. Nature, 2006, 441(7089), 91-95.
42. van Haaften, G.; Vastenhouw, N.L.; Nollen, E.A.; Plasterk, R.H.; Tijsterman, M. Gene interactions in the DNA damage-response pathway identified by genome-wide RNA-interference analysis of synthetic lethality. Proc. Natl. Acad. Sci. USA, 2004, 101(35), 12992-12996.
43. Moy, T.I.; Ball, A.R.; Anklesaria, Z.; Casadei, G.; Lewis, K.; Ausubel, F.M. Identification of novel antimicrobials using a liveanimal infection model. Proc. Natl. Acad. Sci. USA, 2006, 103(27), 10414-10419.
44. Gosai, S.J.; Kwak, J.H.; Luke, C.J.; Long, O.S.; King, D.E.; Kovatch, K.J.; Johnston, P.A.; Shun, T.Y.; Lazo, J.S.; Perlmutter, D.H.; Silverman, G.A.; Pak, S.C. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin alpha1-antitrypsin Z. PLoS One, 2010, 5(11), e15460.
45. (a) Husson, S.J.; Costa, W.S.; Schmitt, C.; Gottschalk, A. Keeping track of worm trackers. WormBook, 2012, 1-17.
46. Buckingham, S.D.; Partridge, F.A.; Sattelle, D.B. Automated, highthroughput, motility analysis in Caenorhabditis elegans and parasitic nematodes: Applications in the search for new anthelmintics. Int. J. Parasitol. Drugs Drug Resist., 2014, 4(3), 226-232.
47. Mathew, M.D.; Mathew, N.D.; Ebert, P.R. WormScan: a technique for high-throughput phenotypic analysis of Caenorhabditis elegans. PLoS One, 2012, 7(3), e33483.
48. Swierczek, N.A.; Giles, A.C.; Rankin, C.H.; Kerr, R.A. Highthroughput behavioral analysis in C. elegans. Nat. Methods, 2011, 8(7), 592-598.
49. Xian, B.; Shen, J.; Chen, W.; Sun, N.; Qiao, N.; Jiang, D.; Yu, T.; Men, Y.; Han, Z.; Pang, Y.; Kaeberlein, M.; Huang, Y.; Han, J.D. WormFarm: a quantitative control and measurement device toward automated Caenorhabditis elegans aging analysis. Aging Cell., 2013, 12(3), 398-409.
50. Giacomotto, J.; Segalat, L. High-throughput screening and small animal models, where are we? Br. J. Pharmacol., 2010, 160(2), 204-216.
51. Chen, X.; Barclay, J.W.; Burgoyne, R.D.; Morgan, A. Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases. Chem. Cent. J., 2015, 9, 65.
52. O'Reilly, L.P.; Luke, C.J.; Perlmutter, D.H.; Silverman, G.A.; Pak, S.C. C. elegans in high-throughput drug discovery. Adv. Drug Deliv. Rev., 2014, 69-70, 247-253.
53. Pukkila-Worley, R.; Feinbaum, R.; Kirienko, N.V.; Larkins-Ford, J.; Conery, A.L.; Ausubel, F.M. Stimulation of host immune defenses by a small molecule protects C. elegans from bacterial infection. PLoS Genet, 2012, 8(6), e1002733.
54. Burns, A.R.; Luciani, G.M.; Musso, G.; Bagg, R.; Yeo, M.; Zhang, Y.; Rajendran, L.; Glavin, J.; Hunter, R.; Redman, E.; Stasiuk, S.; Schertzberg, M.; Angus McQuibban, G.; Caffrey, C.R.; Cutler, S.R.; Tyers, M.; Giaever, G.; Nislow, C.; Fraser, A.G.; MacRae, C.A.; Gilleard, J.; Roy, P.J. Caenorhabditis elegans is a useful model for anthelmintic discovery. Nat. Commun., 2015, 6, 7485.
55. Leung, C.K.; Wang, Y.; Malany, S.; Deonarine, A.; Nguyen, K.; Vasile, S.; Choe, K.P. An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegans. PLoS One, 2013, 8(4), e62166.
56. Lucanic, M.; Garrett, T.; Yu, I.; Calahorro, F.; Asadi Shahmirzadi, A.; Miller, A.; Gill, M.S.; Hughes, R.E.; Holden-Dye, L.; Lithgow, G.J. Chemical activation of a food deprivation signal extends lifespan. Aging Cell, 2016, 15(5), 832-841.
57. Cabreiro, F.; Au, C.; Leung, K.Y.; Vergara-Irigaray, N.; Cocheme, H.M.; Noori, T.; Weinkove, D.; Schuster, E.; Greene, N.D.; Gems, D. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell, 2013, 153(1), 228-239.
58. Viollet, B.; Guigas, B.; Sanz Garcia, N.; Leclerc, J.; Foretz, M.; Andreelli, F. Cellular and molecular mechanisms of metformin: an overview. Clin. Sci(Lond)., 2012, 122(6), 253-270.
59. Collins, J.J.; Evason, K.; Pickett, C.L.; Schneider, D.L.; Kornfeld, K. The anticonvulsant ethosuximide disrupts sensory function to extend C. elegans lifespan. PLoS Genet., 2008, 4(10), e1000230.
60. Driscoll, M.; Dean, E.; Reilly, E.; Bergholz, E.; Chalfie, M. Genetic and molecular analysis of a Caenorhabditis elegans betatubulin that conveys benzimidazole sensitivity. J. Cell. Biol., 1989, 109(6 Pt 1), 2993-3003.
61. Heitman, J.; Movva, N.R.; Hall, M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science, 1991, 253(5022), 905-909.
62. Reis Rodrigues, P.; Kaul, T.K.; Ho, J.H.; Lucanic, M.; Burkewitz, K.; Mair, W.B.; Held, J.M.; Bohn, L.M.; Gill, M.S. Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans. G3(Bethesda), 2016, 6(6), 1695-1705.
63. Kwok, T.C.; Hui, K.; Kostelecki, W.; Ricker, N.; Selman, G.; Feng, Z.P.; Roy, P.J. A genetic screen for dihydropyridine(DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels. PLoS Genet., 2008, 4(5), e1000067.
64. (a) Dickinson, D.J.; Ward, J.D.; Reiner, D.J.; Goldstein, B. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat. Methods, 2013, 10(10), 1028-34.
65. Arribere, J.A.; Bell, R.T.; Fu, B.X.; Artiles, K.L.; Hartman, P.S.; Fire, A.Z. Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans. Genetics, 2014, 198(3), 837-846.
66. Dickinson, D.J.; Goldstein, B. CRISPR-Based Methods for Caenorhabditis elegans Genome Engineering. Genetics, 2016, 202(3), 885-901.
67. Lomenick, B.; Olsen, R.W.; Huang, J. Identification of direct protein targets of small molecules. ACS Chem. Biol., 2011, 6(1), 34-46.
68. Lomenick, B.; Hao, R.; Jonai, N.; Chin, R.M.; Aghajan, M.; Warburton, S.; Wang, J.; Wu, R.P.; Gomez, F.; Loo, J.A.; Wohlschlegel, J.A.; Vondriska, T.M.; Pelletier, J.; Herschman, H.R.; Clardy, J.; Clarke, C.F.; Huang, J. Target identification using drug affinity responsive target stability(DARTS). Proc. Natl. Acad. Sci. USA, 2009, 106(51), 21984-21989.
69. Chin, R.M.; Fu, X.; Pai, M.Y.; Vergnes, L.; Hwang, H.; Deng, G.; Diep, S.; Lomenick, B.; Meli, V.S.; Monsalve, G.C.; Hu, E.; Whelan, S.A.; Wang, J.X.; Jung, G.; Solis, G.M.; Fazlollahi, F.; Kaweeteerawat, C.; Quach, A.; Nili, M.; Krall, A.S.; Godwin, H.A.; Chang, H.R.; Faull, K.F.; Guo, F.; Jiang, M.; Trauger, S.A.; Saghatelian, A.; Braas, D.; Christofk, H.R.; Clarke, C.F.; Teitell, M.A.; Petrascheck, M.; Reue, K.; Jung, M.E.; Frand, A.R.; Huang, J. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature, 2014, 510(7505), 397-401.
70. Savitski, M.M.; Reinhard, F.B.; Franken, H.; Werner, T.; Savitski, M.F.; Eberhard, D.; Martinez Molina, D.; Jafari, R.; Dovega, R.B.; Klaeger, S.; Kuster, B.; Nordlund, P.; Bantscheff, M.; Drewes, G. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science, 2014, 346(6205), 1255784.
71. Lemieux, G.A.; Keiser, M.J.; Sassano, M.F.; Laggner, C.; Mayer, F.; Bainton, R.J.; Werb, Z.; Roth, B.L.; Shoichet, B.K.; Ashrafi, K. In silico molecular comparisons of C. elegans and mammalian pharmacology identify distinct targets that regulate feeding. PLoS Biol., 2013, 11(11), e1001712.
72. Calvert, S.; Tacutu, R.; Sharifi, S.; Teixeira, R.; Ghosh, P.; de Magalhaes, J.P. A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans. Aging Cell, 2016, 15(2), 256-266.
73. Snel, B.; Lehmann, G.; Bork, P.; Huynen, M.A. STRING: a webserver to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res., 2000, 28(18), 3442-3444.
74. Lamb, J.; Crawford, E.D.; Peck, D.; Modell, J.W.; Blat, I.C.; Wrobel, M.J.; Lerner, J.; Brunet, J.P.; Subramanian, A.; Ross, K.N.; Reich, M.; Hieronymus, H.; Wei, G.; Armstrong, S.A.; Haggarty, S.J.; Clemons, P.A.; Wei, R.; Carr, S.A.; Lander, E.S.; Golub, T.R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 2006, 313(5795), 1929-1935.
75. Backus, K.M.; Correia, B.E.; Lum, K.M.; Forli, S.; Horning, B.D.; Gonzalez-Paez, G.E.; Chatterjee, S.; Lanning, B.R.; Teijaro, J.R.; Olson, A.J.; Wolan, D.W.; Cravatt, B.F. Proteome-wide covalent ligand discovery in native biological systems. Nature, 2016, 534(7608), 570-574.
76. Kamat, S.S.; Camara, K.; Parsons, W.H.; Chen, D.H.; Dix, M.M.; Bird, T.D.; Howell, A.R.; Cravatt, B.F. Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay. Nat. Chem. Biol., 2015, 11(2), 164-171.
77. Park, D.; O'Doherty, I.; Somvanshi, R.K.; Bethke, A.; Schroeder, F.C.; Kumar, U.; Riddle, D.L. Interaction of structure-specific and promiscuous G-protein-coupled receptors mediates small-molecule signaling in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA, 2012, 109(25), 9917-9922.
78. Kidd, D.; Liu, Y.; Cravatt, B.F. Profiling serine hydrolase activities in complex proteomes. Biochemistry, 2001, 40(13), 4005-4015.
79. O'Brien, K.P.; Westerlund, I.; Sonnhammer, E.L. OrthoDisease: a database of human disease orthologs. Hum. Mutat., 2004, 24(2), 112-119.
80. Burns, A.R.; Wallace, I.M.; Wildenhain, J.; Tyers, M.; Giaever, G.; Bader, G.D.; Nislow, C.; Cutler, S.R.; Roy, P.J. A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans. Nat. Chem. Biol., 2010, 6(7), 549-557.
81. Rand, J.B.; Johnson, C.D. Genetic pharmacology: interactions between drugs and gene products in Caenorhabditis elegans. Methods Cell. Biol., 1995, 48, 187-204.
82. Kamekura, M.; Oesterhelt, D.; Wallace, R.; Anderson, P.; Kushner, D.J. Lysis of halobacteria in bacto-peptone by bile acids. Appl. Environ. Microbiol., 1988, 54(4), 990-995.
83. Samuel, T.K.; Sinclair, J.W.; Pinter, K.L.; Hamza, I. Culturing Caenorhabditis elegans in axenic liquid media and creation of transgenic worms by microparticle bombardment. J. Vis. Exp., 2014, (90), e51796.
84. Feldman, D.; Krishnan, A. Estrogens in unexpected places: possible implications for researchers and consumers. Environ. Health Perspect., 1995, 103 Suppl 7, 129-133.
85. Solis, G.M.; Petrascheck, M. Measuring Caenorhabditis elegans life span in 96 well microtiter plates. J. Vis. Exp., 2011, (49), pii: 2496.
86. Salon, J.A.; Lodowski, D.T.; Palczewski, K. The significance of G protein-coupled receptor crystallography for drug discovery. Pharmacol. Rev., 2011, 63(4), 901-937.
87. Rex, E.; Hapiak, V.; Hobson, R.; Smith, K.; Xiao, H.; Komuniecki, R. TYRA-2(F01E11.5): a Caenorhabditis elegans tyramine receptor expressed in the MC and NSM pharyngeal neurons. J. Neurochem., 2005, 94(1), 181-191.
88. Hoyer, S.C.; Eckart, A.; Herrel, A.; Zars, T.; Fischer, S.A.; Hardie, S.L.; Heisenberg, M. Octopamine in male aggression of Drosophila. Curr. Biol., 2008, 18(3), 159-167.
89. Ranganathan, R.; Sawin, E.R.; Trent, C.; Horvitz, H.R. Mutations in the Caenorhabditis elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine. J. Neurosci., 2001, 21(16), 5871-5884.
90. Saur, T.; DeMarco, S.E.; Ortiz, A.; Sliwoski, G.R.; Hao, L.; Wang, X.; Cohen, B.M.; Buttner, E.A. A genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug target. PLoS Genet., 2013, 9(2), e1003313.
91. Grad, L.I.; Lemire, B.D. Mitochondrial complex I mutations in Caenorhabditis elegans produce cytochrome c oxidase deficiency, oxidative stress and vitamin-responsive lactic acidosis. Hum. Mol. Genet., 2004, 13(3), 303-314.
92. xO. Cell. Metab., 2012, 15(5), 713-724.
93. McColl, G.; Killilea, D.W.; Hubbard, A.E.; Vantipalli, M.C.; Melov, S.; Lithgow, G.J. Pharmacogenetic analysis of lithiuminduced delayed aging in Caenorhabditis elegans. J. Biol. Chem., 2008, 283(1), 350-357.
94. Onken, B.; Driscoll, M. Metformin induces a dietary restrictionlike state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One, 2010, 5(1), e8758.
95. El-Ami, T.; Moll, L.; Carvalhal Marques, F.; Volovik, Y.; Reuveni, H.; Cohen, E. A novel inhibitor of the insulin/IGF signaling pathway protects from age-onset, neurodegeneration-linked proteotoxicity. Aging Cell, 2014, 13(1), 165-174.
96. Estevez, A.O.; Cowie, R.H.; Gardner, K.L.; Estevez, M. Both insulin and calcium channel signaling are required for developmental regulation of serotonin synthesis in the chemosensory ADF neurons of Caenorhabditis elegans. Dev. Biol., 2006, 298(1), 32-44.
97. David, C.L.; Smith, H.E.; Raynes, D.A.; Pulcini, E.J.; Whitesell, L. Expression of a unique drug-resistant Hsp90 ortholog by the nematode Caenorhabditis elegans. Cell Stress Chaperones, 2003, 8(1), 93-104.
98. Jia, B.; Crowder, C.M. Volatile anesthetic preconditioning present in the invertebrate Caenorhabditis elegans. Anesthesiology, 2008, 108(3), 426-433.
99. Kumar, S.; Dietrich, N.; Kornfeld, K. Angiotensin Converting Enzyme(ACE) Inhibitor Extends Caenorhabditis elegans Life Span. PLoS Genet., 2016, 12(2), e1005866.
100. Carroll, K.; Gomez, C.; Shapiro, L. Tubby proteins: the plot thickens. Nat. Rev. Mol. Cell. Biol., 2004, 5(1), 55-63.
101. Ashrafi, K.; Chang, F.Y.; Watts, J.L.; Fraser, A.G.; Kamath, R.S.; Ahringer, J.; Ruvkun, G. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature, 2003, 421(6920), 268-272.
102. Lemieux, G.A.; Liu, J.; Mayer, N.; Bainton, R.J.; Ashrafi, K.; Werb, Z. A whole-organism screen identifies new regulators of fat storage. Nat. Chem. Biol., 2011, 7(4), 206-213.
103. Geary, T.G.; Kubiak, T.M. Neuropeptide G-protein-coupled receptors, their cognate ligands and behavior in Caenorhabditis elegans. Trends. Pharmacol. Sci., 2005, 26(2), 56-58.
104. Geary, T.G.; Thompson, D.P.; Klein, R.D. Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research. Int. J. Parasitol., 1999, 29(1), 105-112; discussion 113-114.
105. Utzinger, J.; Bergquist, R.; Olveda, R.; Zhou, X.N. Important helminth infections in Southeast Asia diversity, potential for control and prospects for elimination. Adv. Parasitol., 2010, 72, 1-30.
106. Kaminsky, R.; Ducray, P.; Jung, M.; Clover, R.; Rufener, L.; Bouvier, J.; Weber, S.S.; Wenger, A.; Wieland-Berghausen, S.; Goebel, T.; Gauvry, N.; Pautrat, F.; Skripsky, T.; Froelich, O.; Komoin-Oka, C.; Westlund, B.; Sluder, A.; Maser, P. A new class of anthelmintics effective against drug-resistant nematodes. Nature, 2008, 452(7184), 176-180.
107. Holden-Dye, L.; Crisford, A.; Welz, C.; von Samson-Himmelstjerna, G.; Walker, R.J.; O'Connor, V. Worms take to the slo lane: a perspective on the mode of action of emodepside. Invert. Neurosci., 2012, 12(1), 29-36.
108. Geary, T.G.; Thompson, D.P. Caenorhabditis elegans: how good a model for veterinary parasites? Vet. Parasitol., 2001, 101(3-4), 371-386.
109. Somvanshi, V.S.; Ellis, B.L.; Hu, Y.; Aroian, R.V. Nitazoxanide: nematicidal mode of action and drug combination studies. Mol. Biochem. Parasitol., 2014, 193(1), 1-8.
110. Okoli, I.; Coleman, J.J.; Tampakakis, E.; An, W.F.; Holson, E.; Wagner, F.; Conery, A.L.; Larkins-Ford, J.; Wu, G.; Stern, A.; Ausubel, F.M.; Mylonakis, E. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One, 2009, 4(9), e7025.
111. Mylonakis, E.; Casadevall, A.; Ausubel, F.M. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog., 2007, 3(7), e101.
112. Rajamuthiah, R.; Fuchs, B.B.; Jayamani, E.; Kim, Y.; Larkins-Ford, J.; Conery, A.; Ausubel, F.M.; Mylonakis, E. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus. PLoS One, 2014, 9(2), e89189.
113. Martinez, B.A.; Kim, H.; Ray, A.; Caldwell, G.A.; Caldwell, K.A. A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans. Cell. Death Dis., 2015, 6, e1908.
114. Saha, S.; Guillily, M.D.; Ferree, A.; Lanceta, J.; Chan, D.; Ghosh, J.; Hsu, C.H.; Segal, L.; Raghavan, K.; Matsumoto, K.; Hisamoto, N.; Kuwahara, T.; Iwatsubo, T.; Moore, L.; Goldstein, L.; Cookson, M.; Wolozin, B. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J. Neurosci., 2009, 29(29), 9210-9218.
115. Eimer, S.; Donhauser, R.; Baumeister, R. The Caenorhabditis elegans presenilin sel-12 is required for mesodermal patterning and muscle function. Dev. Biol., 2002, 251(1), 178-192.
116. Drake, J.; Link, C.D.; Butterfield, D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide(1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging, 2003, 24(3), 415-420.
117. Link, C.D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA, 1995, 92(20), 9368-9372.
118. Kraemer, B.C.; Zhang, B.; Leverenz, J.B.; Thomas, J.H.; Trojanowski, J.Q.; Schellenberg, G.D. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. USA, 2003, 100(17), 9980-9985.
119. Satyal, S.H.; Schmidt, E.; Kitagawa, K.; Sondheimer, N.; Lindquist, S.; Kramer, J.M.; Morimoto, R.I. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U S A, 2000, 97(11), 5750-5755.
120. van Ham, T.J.; Thijssen, K.L.; Breitling, R.; Hofstra, R.M.; Plasterk, R.H.; Nollen, E.A. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet., 2008, 4(3), e1000027.
121. Oeda, T.; Shimohama, S.; Kitagawa, N.; Kohno, R.; Imura, T.; Shibasaki, H.; Ishii, N. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum. Mol. Genet., 2001, 10(19), 2013-2023.
122. Lu, T.; Aron, L.; Zullo, J.; Pan, Y.; Kim, H.; Chen, Y.; Yang, T.H.; Kim, H.M.; Drake, D.; Liu, X.S.; Bennett, D.A.; Colaiacovo, M.P.; Yankner, B.A. REST and stress resistance in ageing and Alzheimer's disease. Nature, 2014, 507(7493), 448-454.
123. De Haes, W.; Frooninckx, L.; Van Assche, R.; Smolders, A.; Depuydt, G.; Billen, J.; Braeckman, B.P.; Schoofs, L.; Temmerman, L. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc. Natl. Acad. Sci. USA, 2014, 111(24), E2501-2509.